Salem Investment Counselors’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.7K | Sell |
302
-550
| -65% | -$26.8K | ﹤0.01% | 784 |
|
|
2025
Q1 | $29K | Hold |
852
| – | – | ﹤0.01% | 661 |
|
|
2024
Q4 | $33.5K | Sell |
852
-925
| -52% | -$36.4K | ﹤0.01% | 647 |
|
|
2024
Q3 | $83.5K | Buy |
1,777
+2
| +0.1% | +$94 | ﹤0.01% | 480 |
|
|
2024
Q2 | $95.9K | Hold |
1,775
| – | – | ﹤0.01% | 455 |
|
|
2024
Q1 | $121K | Sell |
1,775
-30
| -2% | -$2.05K | ﹤0.01% | 427 |
|
|
2023
Q4 | $113K | Hold |
1,805
| – | – | ﹤0.01% | 426 |
|
|
2023
Q3 | $81.9K | Buy |
1,805
+1,775
| +5,917% | +$80.6K | ﹤0.01% | 450 |
|
|
2023
Q2 | $1.69K | Buy |
+30
| New | +$1.69K | ﹤0.01% | 1018 |
|
|
2017
Q1 | – | Sell |
-650
| Closed | -$13K | – | 560 |
|
|
2016
Q4 | $13K | Buy |
+650
| New | +$13K | ﹤0.01% | 476 |
|